Skip to content

Collegium Pharmaceutical, Inc. COLL Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

CONMED logo
CONMEDCNMD
$6.23M+6.4%
Century Communities logo
Century CommunitiesCCS
$22.22M+279%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$4.06M+16.7%
Essential Utilities logo
Essential UtilitiesWTRG
-$75K+74.4%
Equitable Holdings logo
Equitable HoldingsEQH
$371M-5.1%
Proto Labs logo
Proto LabsPRLB
$128.08M+5.2%

Segments

By segment

See full
Segment$6.18M+225%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.13B+17.9%
Enterprise value$845.67M-0.3%
P/E15.1×-6.8×
P/S1.4×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×